Nicotinamide restored cognitive deficits in vivo using the 3x-Tg AD mice model by selectively reducing Thr231 in a Tau protein associated with microtubule depolymerization and increasing the acetylated α-tubulin [31]. Here, MAPT is linked to Alzheimer disease.